Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
bought 5,000+ shares at $0.89, hope it pays off
Pphm trading weird last 2 days, appears to have bottomed out. Good time to buy. Currently in ph3 nsclc using bavituximab, super safe. Fast track approval and currently have 151 trial sites open to date. Dewdiligence has many shares;)
everyone should check out PPHM. currently in ph3 with fast track and just pr'd today about treating the ebola virus with their drug.
i think years ago what was stated could fall in to "forward looking statements"....yeh a partner would have been nice, but based on what???? we now have a fda ph3 with fast track, alot has changed. ive been vested since dec. 2012 and i hope i wont be in the stock for along time(5 plus years or more) like many here
why hire someone to focus on partnering if pphm wasnt serious about it since they been stating for years they plan to partner?? i dont think they are blowing smoke.
just another opinion
thanks for the info
we have 136 trial sites!!! what are you talking about????!!!!!
believes Bavituximab will get approval
semper never said his sister stated bavi was a definate ph3 approval. geesh where do you get this stuff from boat? i didnt read either that she stated ph3 didnt need to finish the trial. 2 failed trails???????? we all know 1 was corrupt and the other showed it very well could be also, but even if bavi did fail so to speak, did you know that it takes different drugs to treat different diseases? bavi wont help or cure every disease but has show to have an affect on many.....for instance you wouldnt take plavix for a headache, so is that saying that plavix is not a good drug and should be off the market, the answer is no. but would you take plavix if you just had a cardiac stent placed.....YES........so to say bavi failed is misleading just like saying plavix would be a failed drug cause it didnt take away my headache.
its all fun and games to some, but when it comes to money the smart ones take it serious or atleast the ones who have money in the game.
you make fun of someone stating that the co. is being quiet, but then complain when the co. rambles on about partnership over and over. geesh, make your mind up
wrong again dew. didnt you also say that pphm's bavituximab was a placebo and wouldnt get fda ph3 approval.....we now have fda approval for ph3 AND fast track!
low of day has been $1.50
man this board cries more than a 4 year old at a daycare.
your going to compare pphm to the dow (which doesnt reflect our real economy what so ever) the dow is up because they keep printing money. ok next
seems to me the bod is doing everything they can based on this list..not their fault the pps is only at $1.54, blame the co. or person, or persons that messed up the bavi trial back in 2012.........message not directed to poster but others that blame pphm for pps
JOE SHAN (VP/Clin.&Reg. Affairs) – CLINICAL TRIALS:
To expand a bit on what you just said, the initiation of the SUNRISE pivotal Phase III trial in NSCLC was a major event for us, and one that continues to serve as the main focus for our clinical & regulatory teams. As this pivotal trial will involve over 100 clinical sites worldwide that will enroll close to 600 patients, the continued positive & timely execution of tests is paramount to the success of this trial. To that end, we have accomplished a great deal during this past quarter, as the first clinical sites were initiated and with patients already enrolled and being dosed. We also remain on track with our regulatory and ethics approval timeline for rolling out European & Asian-Pacific sites over the next few months.
http://seekingalpha.com/article/2075263-peregrine-pharmaceuticals-management-discusses-q3-2014-results-earnings-call-transcript
yeh and in a couple hours or minutes you'll be posting about how great pphm is and a new partnership will be announced in august from your 'source'
would be nice to see one of those topics come to pass. you been posting these for months
i think there really are people that come on here to get people's hopes up (like partner coming, heard from a contact, etc) then when nothing happens it gets people's hope down and then they think of selling, when infact if some never heard of these rumors they would be still be happy with their investment. i think some people's motives are to instill doubt to make others sell.
means we move up +$1.10 or we drop to $1.10
june is almost over. another prediction wrong.
is the premarket volume of 1,666 a sign they will end the day at $1.66....seen it happen before. lets hope not
i figured you would since 1)your a moderator and 2)you want to know.
if bavi is junk, then how did we get Fast track?
Im sure the move up this week will be pre asco anticipation of hopefully good news and if not back to the 1.70s
Whats the update???
glad you said that, cause i know alot of people come here for real answers to misleading statements.
posted on another board.......
"TWST: Can you give us a realistic picture as to where you see Peregrine in the year 2005?
Mr. King: I see the company as hopefully having partnered Cotara to move that program forward. By then, I would hope that we could be nearing the completion of the Phase III clinical trial. The timing of that will be dependent on the partner. I view the company as really focusing its efforts on vascular targeting and the Vasopermeation Enhancement Agent programs. I view us as having strong clinical programs in both of those areas."
2003
"TWST: What sort of response have you received as far as partnerships is concerned?
Mr. King: Since we made the announcement on Cotara, we have seen a tremendous amount of interest from the introductory level all the way through very advanced due diligence. We are very happy with the response that we received to the drug from the groups that have looked at it. On the vascular targeting front, we have a lot of good opportunities on that side as well."
when hypi states "the stock is in trouble just like this market"
thats not being bullish on pphm. thats comparing pphm to the market.
and yes the market is in trouble i do agree with him on that. the stock market currently doesnt reflect our current economy or unemployement rate.
Stock is in trouble just like this market.
I will say the current levels are probably near the low, but plenty of shares available at these levels.
could you contradict yourself anymore???? make up your mind. werent you the one saying a partnership this month or next based on your opinion and your "source".
pump one day then try and scare the next day.
so the MMs wait till eod to put us in the green, such manipulation.
not true....refresh your browser. longest no trades today was from 9:45-9:52
So court case is dismissed and bod has their options now, so where is the partnership news????
if you had that many shares you wouldnt post negative comments all the time. anyone can make up the amount of shares they hold, who cares. the point is your always negative. sell and move on with your so called "73,000" shares
nobody knows what is going on behind close doors. we have FT and money in the bank, so sit tight.
pointing out the fact that if its so obvious and simple then why bring it up, unless your just trying to always point out the negative of the co. and assuming theyre diluting at mass quantities
of course you would say that